DHR
丹納赫 DANAHER CORP /DE/
+3.38 (+1.62%)211.74USD1.4M成交股數149B市值37.5本益比(近四季)5.9股價營收比+5.5%營收年增(近四季)2026-10-20下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 6.3B+6% | 6.0B+4% | 6.8B+18% | 6.1B+5% | 5.9B+2% | 5.7B-10% | 5.8B+3% | 5.7B-3% | 5.8B | 6.4B | 5.6B | 5.9B |
| 營業成本 | 2.7B | 2.4B | 2.9B | 2.5B | 2.4B | 2.2B | 2.4B | 2.3B | 2.3B | – | 2.3B | 2.6B |
| 毛利 | 3.6B+2% | 3.6B+2% | 4.0B+17% | 3.5B+3% | 3.5B+1% | 3.5B-7% | 3.4B+4% | 3.4B+3% | 3.5B | 3.8B | 3.3B | 3.3B |
| 毛利率 | 57.6% | 60.3% | 58.0% | 58.2% | 59.3% | 61.2% | 58.7% | 59.7% | 60.2% | 59.0% | 58.2% | 56.1% |
| 研發費用 | 412M | 387M | 438M | 378M | 403M | 379M | 383M | 391M | 368M | – | 362M | 361M |
| 銷售管理費用 | 2.1B | 1.9B | 2.0B | 2.0B | 2.4B | 1.9B | 2.1B | 1.9B | 1.8B | – | 1.7B | 1.8B |
| 營業利益 | 1.1B+48% | 1.3B+5% | 1.5B+57% | 1.2B-1% | 760M-42% | 1.3B-5% | 958M-19% | 1.2B+0% | 1.3B | 1.3B | 1.2B | 1.2B |
| 營業利益率 | 18.0% | 22.6% | 22.0% | 19.1% | 12.8% | 22.2% | 16.5% | 20.3% | 22.6% | 20.9% | 21.1% | 19.7% |
| 稅後淨利 | 870M+57% | 1.0B+8% | 1.2B+46% | 908M+0% | 555M-49% | 954M-12% | 818M-28% | 907M-18% | 1.1B | 1.1B | 1.1B | 1.1B |
| 淨利率 | 13.9% | 17.3% | 17.5% | 15.0% | 9.3% | 16.6% | 14.1% | 15.8% | 18.8% | 16.8% | 20.1% | 18.7% |
| 稀釋 EPS | 1.23+60% | 1.45+10% | 1.69+51% | 1.27+4% | 0.77-47% | 1.32-9% | 1.12-26% | 1.22-18% | 1.45 | 1.45 | 1.51 | 1.49 |
| 稀釋股數 | 708M | 711M | 716M | 714M | 719M | 721M | 729M | 742M | 749M | – | 746M | 745M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 4.3B | 5.7B | 4.6B | 1.5B | 3.0B | 2.0B | 2.6B | 2.4B | 7.0B | 5.9B | 12.3B | 8.6B |
| 應收帳款 | 4.0B | 3.8B | 3.9B | 3.8B | 3.6B | 3.5B | 3.5B | 3.3B | 3.4B | 3.9B | 4.2B | 4.2B |
| 存貨 | 3.3B | 2.6B | 2.5B | 2.7B | 2.7B | 2.5B | 2.7B | 2.7B | 2.6B | 2.6B | 3.0B | 3.2B |
| 總資產 | 92.4B | 83.5B | 83.5B | 79.9B | 81.6B | 79.1B | 80.6B | 78.6B | 83.4B | 84.5B | 87.7B | 84.9B |
| 有息負債 | 25.1B | 17.6B | 18.4B | 16.8B | 16.9B | 16.0B | 16.3B | 16.3B | 16.4B | 16.7B | 19.5B | 18.3B |
| 總負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 股東權益 | 52.6B | 52.9B | 52.5B | 51.1B | 52.3B | 50.8B | 51.3B | 49.9B | 53.4B | 53.5B | 52.4B | 51.7B |
| 負債比 | – | – | – | – | – | – | – | – | – | – | – | – |
| 淨現金(現金 − 有息負債) | −20.8B | −11.9B | −13.8B | −15.3B | −13.9B | −14.0B | −13.7B | −13.9B | −9.4B | −10.8B | −7.2B | −9.7B |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 1.3B+2% | – | – | – | 1.3B | – | – | 1.7B | – | – | – |
| 資本支出 | – | 237M | – | – | – | 245M | – | – | 291M | – | – | – |
| 自由現金流 | – | 1.1B+3% | – | – | – | 1.1B | – | – | 1.4B | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | 0.00 | – | – | – | 1.1B | – | – | 0.00 | – | – | – |
| 現金股利 | – | 226M | – | – | – | 194M | – | – | 177M | – | – | – |
| 自由現金流率 | – | 18.2% | – | – | – | 18.4% | – | – | 25.0% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 24.6B
| Diagnostics | 9.9B | 40.5% | +1.6% |
|---|---|---|---|
| Life Sciences | 7.3B | 29.9% | +0.1% |
| Biotechnology | 7.3B | 29.7% | +7.9% |
地區2025 年度 · 24.6B
| North America | 10.4B | 42.2% | +0.6% |
|---|---|---|---|
| High Growth Markets | 7.0B | 28.6% | +2.2% |
| Western Europe | 5.9B | 24.2% | +8.8% |
| Other Developed Markets | 1.3B | 5.1% | -0.1% |
產品／服務2025 年度 · 24.6B
| Revenuefrom Contractwith Customer Measurement Recurring | 20.1B | 81.9% | +3.9% |
|---|---|---|---|
| Revenuefrom Contractwith Customer Measurement Nonrecurring | 4.4B | 18.1% | -1.5% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 24.6B | +2.9% | 3.6B | 14.7% | 5.05 | 5.3B |
| FY2024 | 23.9B | -0.1% | 3.9B | 16.3% | 5.29 | 5.3B |
| FY2023 | 23.9B | -10.3% | 4.8B | 19.9% | 6.38 | 5.8B |
| FY2022 | 26.6B | +7.4% | 7.2B | 27.1% | 9.66 | 7.4B |
| FY2021 | 24.8B | +11.3% | 6.4B | 25.9% | 8.61 | 7.1B |
| FY2020 | 22.3B | +24.4% | 3.6B | 16.4% | 4.89 | 5.4B |
| FY2019 | 17.9B | +5.1% | 3.0B | 16.8% | 4.05 | 3.3B |
| FY2018 | 17.0B | – | 2.7B | 15.5% | 3.74 | 3.4B |